technology+therapeutics

The drug, avacopan, which will be available under brand name Tavneos in the next few weeks, will have a wholesale price of between $150,000 and $200,000 per patient per year.

The 26 research institutions have run nearly 4,600 trials testing medicines and, so far, 641 sets of results have been made available.

America is the cradle of breakthrough pharmaceutical innovation. U.S. biopharmaceutical companies create nearly two in every three new medicines.

The Covid-19 treatment molnupiravir was developed using funding from the National Institutes of Health and the Department of Defense.

Eli Lilly CEO David Ricks joins CNBC's Meg Tirrell to discuss how a pending drug pricing bill would "fundamentally restructure" the company's business model.

Antiviral drugs that keep some coronavirus patients out of the hospital are badly needed, and investors know it.

Large pharmaceutical companies are nowhere near as important to real drug innovation as they purport to be.

The drug, named molnupiravir, reduces the risk of hospitalization or death by 50% in Covid-19 patients with mild and moderate symptoms compared with placebo, Merck said.

The evolving landscape for biosimilars.

This lecture will describe the US FDA approval of aducanumab (Aduhelm) for Alzheimer disease and the implications the approval has had across the US health care system.

The body in charge of pricing and reimbursement in Germany has downgraded the extent of additional benefit offered by Gilead’s Veklury for treating COVID-19 patients.

US FDA’s Oncology Center of Excellence is eager to pilot test ‘Drug Development Snapshots’ as a potential tool to optimize communication for drugs receiving the Breakthrough Therapy Designation.

US FDA research funded under BSUFA III will investigate what kind of safety data is needed for interchangeability.

Amnesty international has warned covid-19 developers not to put profits before lives.

In the United States, some health experts have worried that promoting the therapy, which the government covers at a cost of $2,100 per dose, was taking away time and money from the effort to get more Americans vaccinated against Covid.